First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomide-Reference-Cited by-同舟云学术

First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomide

Published:2020-02 Issue:3 Volume:146 Page:451-458
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Hata Nobuhiro^ORCID,Mizoguchi Masahiro,Kuga Daisuke,Hatae Ryusuke,Akagi Yojiro,Sangatsuda Yuhei,Amemiya Takeo,Michiwaki Yuhei,Fujioka Yutaka,Takigawa Kosuke,Suzuki Satoshi O.,Yoshitake Tadamasa,Togao Osamu,Hiwatashi Akio,Yoshimoto Koji,Iihara Koji

Funder

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Neurology,Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-019-03339-0.pdf

Reference25 articles.

1. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996

2. Stupp R, Taillibert S, Kanner A et al (2017) Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial. JAMA 318:2306–2316

3. Chinot OL, Wick W, Mason W et al (2014) Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med. 370:709–722

4. Gilbert MR, Dignam JJ, Armstrong TS et al (2014) A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med 370:699–708

5. Chinot OL, Nishikawa R, Mason W et al (2016) Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio. Neuro Oncol 18:1313–1318

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bevacizumab for Glioblastoma Multiforme: A Literature Review;JAP Academy Journal;2024-06-01

2. Supramaximal Resection Can Prolong the Survival of Patients with Cortical Glioblastoma: A Volumetric Study;Neurologia medico-chirurgica;2023-08-15

3. Induction of Ferroptosis in Glioblastoma and Ovarian Cancers by a New Pyrrole Tubulin Assembly Inhibitor;Journal of Medicinal Chemistry;2022-11-17

4. Detection of mutation profiles and tumor mutation burden of cerebrospinal fluid circulating DNA by a cancer genomic panel sequencing in glioma patients;Clinica Chimica Acta;2022-09

5. Brain Co‐Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy;Advanced Materials;2022-07-17